Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

Laurence L. Greenhill, Doris H. Beyer, Jami Finkleson, David Shaffer, Joseph Biederman, C. Keith Conners, Christopher Gillberg, Michael Huss, Peter Jensen, James L. Kennedy, Rachel Klein, Judith Rapoport, Terje Sagvolden, Tom Spencer, James M. Swanson, Nora Volkow

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

Original languageEnglish (US)
JournalJournal of Attention Disorders
Volume6
Issue numberSUPPL. 1
StatePublished - 2002
Externally publishedYes

Fingerprint

Methylphenidate
Attention Deficit Disorder with Hyperactivity
Guidelines
Therapeutics
Safety
Practice Guidelines
Consensus

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Greenhill, L. L., Beyer, D. H., Finkleson, J., Shaffer, D., Biederman, J., Conners, C. K., ... Volkow, N. (2002). Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Journal of Attention Disorders, 6(SUPPL. 1).

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. / Greenhill, Laurence L.; Beyer, Doris H.; Finkleson, Jami; Shaffer, David; Biederman, Joseph; Conners, C. Keith; Gillberg, Christopher; Huss, Michael; Jensen, Peter; Kennedy, James L.; Klein, Rachel; Rapoport, Judith; Sagvolden, Terje; Spencer, Tom; Swanson, James M.; Volkow, Nora.

In: Journal of Attention Disorders, Vol. 6, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

Greenhill, LL, Beyer, DH, Finkleson, J, Shaffer, D, Biederman, J, Conners, CK, Gillberg, C, Huss, M, Jensen, P, Kennedy, JL, Klein, R, Rapoport, J, Sagvolden, T, Spencer, T, Swanson, JM & Volkow, N 2002, 'Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder', Journal of Attention Disorders, vol. 6, no. SUPPL. 1.
Greenhill LL, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK et al. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Journal of Attention Disorders. 2002;6(SUPPL. 1).
Greenhill, Laurence L. ; Beyer, Doris H. ; Finkleson, Jami ; Shaffer, David ; Biederman, Joseph ; Conners, C. Keith ; Gillberg, Christopher ; Huss, Michael ; Jensen, Peter ; Kennedy, James L. ; Klein, Rachel ; Rapoport, Judith ; Sagvolden, Terje ; Spencer, Tom ; Swanson, James M. ; Volkow, Nora. / Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. In: Journal of Attention Disorders. 2002 ; Vol. 6, No. SUPPL. 1.
@article{a42fc25c256c460ea7bf5f214a831802,
title = "Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder",
abstract = "Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.",
author = "Greenhill, {Laurence L.} and Beyer, {Doris H.} and Jami Finkleson and David Shaffer and Joseph Biederman and Conners, {C. Keith} and Christopher Gillberg and Michael Huss and Peter Jensen and Kennedy, {James L.} and Rachel Klein and Judith Rapoport and Terje Sagvolden and Tom Spencer and Swanson, {James M.} and Nora Volkow",
year = "2002",
language = "English (US)",
volume = "6",
journal = "Journal of Attention Disorders",
issn = "1087-0547",
publisher = "SAGE Publications Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

AU - Greenhill, Laurence L.

AU - Beyer, Doris H.

AU - Finkleson, Jami

AU - Shaffer, David

AU - Biederman, Joseph

AU - Conners, C. Keith

AU - Gillberg, Christopher

AU - Huss, Michael

AU - Jensen, Peter

AU - Kennedy, James L.

AU - Klein, Rachel

AU - Rapoport, Judith

AU - Sagvolden, Terje

AU - Spencer, Tom

AU - Swanson, James M.

AU - Volkow, Nora

PY - 2002

Y1 - 2002

N2 - Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

AB - Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

UR - http://www.scopus.com/inward/record.url?scp=1642399677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642399677&partnerID=8YFLogxK

M3 - Article

C2 - 12685523

AN - SCOPUS:1642399677

VL - 6

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

SN - 1087-0547

IS - SUPPL. 1

ER -